Detalles de la búsqueda
1.
Benefit and toxicity of programmed death-1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study.
Br J Dermatol
; 187(3): 401-410, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35293617
2.
High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanoma.
Cancer
; 124(18): 3706-3714, 2018 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29975414
3.
A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607).
Cancer
; 123(14): 2688-2697, 2017 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28334439
4.
Impact of Age on Outcomes with Immunotherapy for Patients with Melanoma.
Oncologist
; 22(8): 963-971, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28476944
5.
Immune-Related Adverse Events in the Setting of PD-1/L1 Inhibitor Combination Therapy.
Oncologist
; 25(3): e398-e404, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32162817
6.
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy.
J Immunother Cancer
; 12(4)2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38599660
7.
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0.
J Immunother Cancer
; 11(10)2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37852736
8.
Side effects in melanoma patients receiving adjuvant interferon alfa-2b therapy: a nurse's perspective.
Support Care Cancer
; 20(8): 1601-11, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22562583
9.
Urgent access to a specialty care melanoma clinic is associated with a higher rate of melanoma detection.
J Am Acad Dermatol
; 64(6): 1060-7, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21453985
10.
Radiological dynamics and SITC-defined resistance types of advanced melanoma during anti-PD-1 monotherapy: an independent single-blind observational study on an international cohort.
J Immunother Cancer
; 9(2)2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33632901
11.
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer.
J Immunother Cancer
; 9(8)2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34389617
12.
Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti-PD-1 Monotherapy.
Clin Cancer Res
; 27(21): 5993-6000, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34376536
13.
Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors.
J Immunother Cancer
; 9(7)2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34281989
14.
Immune Checkpoint Inhibitor-Based Therapy as a Backbone in Cancer Treatment.
J Adv Pract Oncol
; 11(3): 231-233, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33598316
15.
Your patient with melanoma: staging, prognosis, and treatment.
Oncology (Williston Park)
; 23(8 Suppl): 13-21, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19860037
16.
Meeting the Challenge of Immune-Related Adverse Events With Optimized Telephone Triage and Dedicated Oncology Acute Care.
J Adv Pract Oncol
; 10(Suppl 1): 9-20, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33014514
17.
Caring for Patients Treated With Checkpoint Inhibitors for the Treatment of Metastatic Merkel Cell Carcinoma.
Semin Oncol Nurs
; 35(5): 150924, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31514991
18.
Immunotherapy in Gynecologic Cancers: What We Know Now and Where We Are Headed.
Am Soc Clin Oncol Educ Book
; 39: e126-e140, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31099679
19.
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0
J. immunotherap. cancer
; 11(10): 1-39, 20231001. tab
Artículo
en Inglés
| BIGG | ID: biblio-1525933
20.
An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0.
J Immunother Cancer
; 6(1): 44, 2018 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-29848375